Infanrix IPV inj. susp. i.m. pre-filled syr.

Ülke: Belçika

Dil: İngilizce

Kaynak: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktif bileşen:

Diphtheria Toxoid (DT) >= 30 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/0,5 ml; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Poliovirus Type 1 (inactivated) 40 D-antigen U/0,5 ml; Tetanus Toxoid >= 40 IU/dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Bordetella Pertussis Pertactin 8 µg/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/0,5 ml

Mevcut itibaren:

GlaxoSmithKline Biologicals SA-NV

ATC kodu:

J07CA02

INN (International Adı):

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Farmasötik formu:

Suspension for injection

Kompozisyon:

Diphteria Antigen, Adsorbed; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Uygulama yolu:

Intramuscular use

Terapötik alanı:

Diphtheria-Pertussis-Poliomyelitis-Tetanus

Ürün özeti:

CTI code: 212152-02 - Pack size: 10 x 1 dose (0.5 (0.5) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 212152-01 - Pack size: 1 dose (0.5 (0.5) - Commercialisation status: NO - FMD code: 05400571000808 - CNK code: 1552215 - Delivery mode: Medical prescription

Yetkilendirme durumu:

Commercialised: Yes

Yetkilendirme tarihi:

2000-03-13